Novel Insights into PGM2L1 as a Prognostic Biomarker in Cholangiocarcinoma: Implications for Metabolic Reprogramming and Tumor Microenvironment Modulation

Guo-Wei WuYi-Hsien HsiehYi-Chung ChienLi-Yuan BaiYung-Luen Yu2026-02-052026-02-052025-02-1110.7150/ijms.106566https://scholars.csmu.edu.tw/handle/123456789/5189[SDGs]SDG3Novel Insights into PGM2L1 as a Prognostic Biomarker in Cholangiocarcinoma: Implications for Metabolic Reprogramming and Tumor Microenvironment Modulationjournal-article